Dare Bioscience, Inc. Other Non-Current Assets
Dare Bioscience, Inc. (DARE) had Other Non-Current Assets of $2.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Noncurrent $2.55M.
- 2026-03-31: Other Assets, Noncurrent $2.44M.
- 2025-12-31: Other Assets, Noncurrent $1.01M.
- 2025-09-30: Other Assets, Noncurrent $1.02M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.55M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.44M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.01M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.07M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.11M 10-K · filed 2026-03-26 | $1.10M 10-K · filed 2025-03-31 |
| 2024-09-30 | $533.94K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $528.57K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $654.53K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $599.59K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $796.43K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $920.88K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $799.33K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $254.29K 10-K · filed 2024-03-28 | $722.72K 10-K · filed 2023-03-30 |
| 2022-09-30 | $736.51K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.26M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $485.12K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $535.23K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $738.28K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $887.86K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $528.87K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $634.96K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $738.66K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $840.57K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $935.33K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $632.65K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $692.30K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $751.35K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $577.97K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $617.50K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $657.03K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $686.06K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $723.19K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $2.80K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $2.80K 8-K/A · filed 2017-10-02 | |
| 2017-03-31 | $230.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $12.68K 10-K · filed 2018-03-28 | $230.00K 10-K · filed 2017-03-31 |
| 2016-09-30 | $230.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $230.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $230.00K 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $347.00K 10-K/A · filed 2017-06-13 | |
| 2015-09-30 | $610.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $653.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $469.00K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $215.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $120.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $124.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $130.00K 10-Q · filed 2014-05-27 | |
| 2013-12-31 | $135.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |